Biostar Pharmaceuticals, Inc. Receivables, Fair Value Disclosure
Biostar Pharmaceuticals, Inc. had Receivables, Fair Value Disclosure of $0 as of 2015-12-31, per its 10-K filed 2016-04-14.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Financial Instruments, Financial Assets, Balance Sheet Groupings
us-gaap:ReceivablesFairValueDisclosure · last filed 2016-04-14
- 2015-12-31: Receivables, Fair Value Disclosure $0.00.
- 2015-09-30: Receivables, Fair Value Disclosure $9.44M.
- 2015-06-30: Receivables, Fair Value Disclosure $9.85M.
- 2015-03-31: Receivables, Fair Value Disclosure $9.82M.
| Period end | Receivables, Fair Value Disclosure |
|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-04-14 |
| 2015-09-30 | $9.44M 10-Q · filed 2015-11-23 |
| 2015-06-30 | $9.85M 10-Q · filed 2015-08-19 |
| 2015-03-31 | $9.82M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $9.77M 10-K · filed 2016-04-14 |
| 2013-12-31 | $9.82M 10-K · filed 2015-04-15 |